Two Sigma Securities, LLC Adial Pharmaceuticals, Inc. Transaction History

Two Sigma Securities, LLC

  • $10.3 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$0.21 - $0.37 $5,891 - $10,381
-28,057 Reduced 57.56%
20,691 $4,000
Q1 2023

May 15, 2023
BUY
$0.24 - $0.56 $4,167 - $9,724
17,365 Added 55.33%
48,748 $17,000
Q4 2022

Feb 14, 2023
BUY
$0.2 - $0.31 $2,716 - $4,210
13,581 Added 76.29%
31,383 $6,000
Q3 2022

Nov 14, 2022
BUY
$0.03 - $0.58 $534 - $10,325
17,802 New
17,802 $6,000

Others Institutions Holding ADIL

# of Institutions
1
Shares Held
5.5K
Call Options Held
0
Put Options Held
0
View Full List

About ADIAL PHARMACEUTICALS, INC.

ADIL Quotes by TradingView
  • Ticker ADIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,854,000
  • Market Cap $28.2M
  • Description
  • Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focu...
More about ADIL
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email